Abstract
Breast cancer is the leading cause of malignancy among women worldwide. In Brazil, about 50% of patients present with locally advanced or metastatic disease at the diagnostic. Neoadjuvant chemotherapy has been used as the standard treatment. The pathological response to therapy is an important prognostic factor. Only 20% of patients achieve complete pathological response and do benefit f…